InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Ovid Therapeutics Inc.

OVID Clue Score44
United States Fiscal year ends December CIK 0001636651 Results filed 18 Mar 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

10
Insider
Date
Role
Action
Shares
Price
Amount
Margaret A. Alexander
27 Jan 2025
President and COO
Buy
6,810
$0.73
$4.97K
Jeremy M Levin
18 Mar 2024
CEO
Buy
18,248
$2.76
$50.36K
Jeremy M Levin
28 Aug 2020
CEO
Buy
8,488
$5.84
$49.57K
Jeremy M Levin
8 Oct 2019
CEO
Buy
60,000
$2.50
$150.00K
Takeda Pharmaceutical Co Ltd
8 Oct 2019
10% owner
Buy indirect
2,000,000
$2.50
$5.00M
Karen Bernstein
26 Feb 2019
Director
Buy
10,000
$2.02
$20.21K
Jeremy M Levin
22 Feb 2019
CEO
Buy
75,000
$2.00
$150.00K
Douglas E Williams
14 Aug 2018
Director
Buy
5,000
$6.49
$32.44K
Karen Bernstein
14 Aug 2018
Director
Buy
10,000
$6.23
$62.30K
Jeremy M Levin
25 Aug 2017
CEO
Buy
15,334
$7.15
$109.64K
Show all 17 transactions →

What was left out

Form 4 filings counted 157
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 14,846,701
Sales filed before the plan box existed 1
History held since 10 May 2017